CytoAgents

About:

CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.

Website: https://www.cytoagents.com/

Top Investors: Innovation Works, AlphaLab Health, National Institutes of Health, Richard King Mellon Foundation, EQx Fund

Description:

CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.